UnknownNot Applicable

Intrapartum Glucose and Insulin Compared to Glucose Alone in Diabetic Women

Israel200 participantsStarted 2017-10-31

Plain-language summary

This study aims to examine the effect of intrapartum treatment of diabetic women with combined glucose and constant insulin infusion compared to glucose alone on the incidence of neonatal hypoglycemia. Pregnant women with diabetes in pregnancy will be randomly divided during labor to 2 groups: group 1, will receive intravenous glucose with constant insulin infusion; group 2 will receive intravenous glucose alone. The primary outcome is the incidence of neonatal hypoglycemia.

Who can participate

Age range18 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \>37 weeks gestation * gestational diabetes mellitus according to Carpenter and Coustan * pregestational diabetes mellitus Exclusion Criteria: * Intrauterine fetal death * estimated fetal weight\<10p * multiple gestation * major fetal malformations

What they're measuring

Neonatal hypoglycemia

Timeframe: 2-3 hours postpartum

Trial details

NCT IDNCT03273881

SponsorHaEmek Medical Center, Israel

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-31

Contact for this trial

Gali Gali, MD

972-4-6494035 galit_ga@clalit.org.il

View on ClinicalTrials.gov More Obstetric Labor trials